Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter
Stock Region Penny Picks Watchlist Newsletter
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions. Stock Region is not responsible for any financial losses incurred.
The market has been buzzing with activity, and we’ve got some exciting updates to share. From groundbreaking FDA approvals to strategic partnerships and mergers, there’s a lot to unpack. Let’s dive in and see what’s making waves in the stock world!
Breaking News & Highlights
$VNDA - Vanda Pharmaceuticals
FDA Approval for BYSANTI™ (milsaperidone)
Vanda Pharmaceuticals just got the green light from the FDA for BYSANTI™, a new treatment for Bipolar I Disorder and Schizophrenia. This is a huge win for psychiatric innovation, and it’s exciting to see a new chemical entity entering the market. Could this be a game-changer for mental health treatment? Time will tell, but it’s definitely one to watch.
$COCH - Envoy Medical
Three New Patents Secured
Envoy Medical is flexing its innovation muscles with three new patents in the fully implanted hearing space. This move strengthens their competitive edge and positions them as a leader in the industry. If you’re into med-tech, this could be a stock to keep on your radar.
$RNAZ - TransCode Therapeutics
Preclinical Testing Success
TransCode Therapeutics announced promising preclinical results for their RIG-I immunotherapeutic candidate. This is a step forward in their development pipeline, and while it’s still early days, the potential here is intriguing.
$TOPS - TOP Ships Inc.
Big Acquisition News
TOP Ships is making waves with an agreement to acquire nine ECO MR product tankers. With a potential revenue backlog of $679 million, this is a bold move that could pay off big time. Shipping stocks can be volatile, but this one’s making a strong case for itself.
$GETY - Getty Images & Shutterstock
Merger Gets DOJ Clearance
The U.S. Department of Justice has given the green light for the Getty Images and Shutterstock merger. This is a major development in the visual content space, and it’ll be interesting to see how this powerhouse duo reshapes the industry.
$ALUR - Allurion
FDA Approval Secured
Allurion has received FDA approval, marking a significant milestone for the company. Details are sparse, but FDA approvals often signal big things ahead.
$MYGN - Myriad Genetics
Earnings Beat Expectations
Myriad Genetics reported earnings of $0.04 per share, smashing analyst expectations of -$0.01. While sales saw a slight dip, this earnings beat is a positive sign. Could this be the start of a turnaround story?
$VIR - Vir Biotechnology
Positive Phase 1 Results
Vir Biotechnology shared encouraging Phase 1 results for their prostate cancer treatment, VIR-5500. With dose-dependent anti-tumor activity observed, this is a promising development in the fight against cancer.
$SDST - Stardust Power
Joins Cornerstone Consortium
Stardust Power is stepping up to support U.S. critical minerals and industrial base resilience. This move aligns with growing interest in domestic supply chains and could position them as a key player in this space.
$LRMR - Larimar Therapeutics
FDA Breakthrough Therapy Designation
Larimar Therapeutics received FDA Breakthrough Therapy Designation for Nomlabofusp in FA. With a planned BLA submission in June 2026, this is a stock to watch for long-term growth potential.
$ARDX - Ardelyx
LPGA Partnership Announced
Ardelyx is teaming up with the LPGA to break the stigma around digestive health issues. This partnership is a unique way to raise awareness and could help the company connect with a broader audience.
$ZSPC - zSpace
Empowering At-Promise Youth
zSpace is partnering with Eight Million Stories to support at-promise youth. This is a feel-good story with a social impact angle, and it’s great to see companies investing in the future.
$HTCR - HeartCore
Share Repurchase Program
HeartCore has authorized a $2 million share repurchase program. This move reflects confidence in their business and a commitment to shareholder value.
$TLIH - Ten-League International Holdings
Fiscal Year 2025 Guidance
Ten-League International Holdings has announced their fiscal year 2025 guidance. While details are still emerging, guidance updates are always worth noting.
$BRTX - BioRestorative
Global Protection for ThermoStem®
BioRestorative is expanding global protection for ThermoStem®, a potential alternative to GLP-1 drugs. This could be a game-changer in the cell-based therapy space.
$RIME - SemiCab
Pilot with Coca-Cola India
SemiCab has been awarded a pilot with Coca-Cola India. This partnership could open doors to significant opportunities in the logistics space.
$EDSA - Edesa Biotech
Positive Phase 3 Results
Edesa Biotech reported additional positive results from their Phase 3 Paridiprubart study. This is a strong signal for their pipeline and future prospects.
$XWEL - XWELL
Private Placement Announced
XWELL has announced a $31.3 million private placement. This move provides them with additional capital to fuel growth initiatives.
The market is alive with innovation, partnerships, and strategic moves. Whether it’s FDA approvals, mergers, or earnings surprises, there’s no shortage of opportunities to explore. Remember, the stock market is a rollercoaster—buckle up and enjoy the ride!
Stay savvy,
The Stock Region Team
Disclaimer: This newsletter is not financial advice. Always consult with a financial advisor before making investment decisions.